APA (7th ed.) Citation

Byrne, B., Castelli, J., Jain, V., Sitaraman Das, S., & Zhang, J. (2024). 657P Cipaglucosidase alfa + miglustat in late-onset Pompe disease: Two non-ambulatory patients switching from high-dose, high-frequency alglucosidase alfa. Neuromuscular disorders : NMD, 43, 104441. https://doi.org/10.1016/j.nmd.2024.07.724

Chicago Style (17th ed.) Citation

Byrne, B., J. Castelli, V. Jain, S. Sitaraman Das, and J. Zhang. "657P Cipaglucosidase Alfa + miglustat in Late-onset Pompe Disease: Two Non-ambulatory Patients Switching from High-dose, High-frequency Alglucosidase Alfa." Neuromuscular Disorders : NMD 43 (2024): 104441. https://doi.org/10.1016/j.nmd.2024.07.724.

MLA (9th ed.) Citation

Byrne, B., et al. "657P Cipaglucosidase Alfa + miglustat in Late-onset Pompe Disease: Two Non-ambulatory Patients Switching from High-dose, High-frequency Alglucosidase Alfa." Neuromuscular Disorders : NMD, vol. 43, 2024, p. 104441, https://doi.org/10.1016/j.nmd.2024.07.724.